KEGG   DRUG: Raloxifene hydrochloride
Entry
D02217                      Drug                                   
Name
Raloxifene hydrochloride (JAN/USP);
LY 156758;
Evista (TN)
Product
  Generic
Formula
C28H27NO4S. HCl
Exact mass
509.1428
Mol weight
510.04
Structure
Simcomp
Class
Hormonal agent
 DG01619  Estrogen receptor antagonist/modulator
  DG01621  Selective estrogen receptor modulator
Musculo-skeletal system agent
 DG03232  Osteoporosis agent
Remark
Therapeutic category: 3999
ATC code: G03XC01
Chemical structure group: DG00476
Product (DG00476): D02217<JP/US> D10606<JP>
Efficacy
Osteoporosis agent, Selective estrogen receptor modulator (SERM)
  Disease
Osteoporosis [DS:H01593]
Comment
Benzothiophene derivative
Target
NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]
  Pathway
hsa04915  Estrogen signaling pathway
hsa04961  Endocrine and other factor-regulated calcium reabsorption
Interaction
Structure map
map07043  Antineoplastics - hormones
map07047  Osteoporosis drugs
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 G GENITO URINARY SYSTEM AND SEX HORMONES
  G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
   G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
    G03XC Selective estrogen receptor modulators
     G03XC01 Raloxifene
      D02217  Raloxifene hydrochloride (JAN/USP) <JP/US>
USP drug classification [BR:br08302]
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
  Selective Estrogen Receptor Modifying Agents
   Raloxifene
    D02217  Raloxifene hydrochloride (JAN/USP)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D02217  Raloxifene hydrochloride (JAN/USP)
Drug groups [BR:br08330]
 Hormonal agent
  DG01619  Estrogen receptor antagonist/modulator
   DG01621  Selective estrogen receptor modulator
    DG00476  Raloxifene
     D02217  Raloxifene hydrochloride
 Musculo-skeletal system agent
  DG03232  Osteoporosis agent
   DG00476  Raloxifene
    D02217  Raloxifene hydrochloride
Drug classes [BR:br08332]
 Musculo-skeletal system agent
  DG03232  Osteoporosis agent
   D02217  Raloxifene hydrochloride
Target-based classification of drugs [BR:br08310]
 Nuclear receptors
  Estrogen like receptors
   Estrogen receptor
    NR3A (ESR)
     D02217  Raloxifene hydrochloride (JAN/USP) <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D02217
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D02217
Drug groups [BR:br08330]
 Hormonal agent
  DG01619  Estrogen receptor antagonist/modulator
   DG01621  Selective estrogen receptor modulator
    DG00476  Raloxifene
 Musculo-skeletal system agent
  DG03232  Osteoporosis agent
   DG00476  Raloxifene
Other DBs
CAS: 82640-04-8
PubChem: 7849276
ChEBI: 50740
LigandBox: D02217
NIKKAJI: J553.049K
LinkDB
KCF data

ATOM        35
            1   X   Cl   28.3116  -20.4635
            2   C8y C    19.6000  -24.7100
            3   C8x C    19.6000  -26.1100
            4   C8x C    20.7900  -26.8100
            5   C8y C    22.0500  -26.1100
            6   C8x C    22.0500  -24.7100
            7   C8x C    20.7900  -24.0100
            8   C5a C    18.4100  -24.0100
            9   C8y C    17.2200  -24.7100
            10  O5a O    18.4100  -22.6100
            11  O2a O    23.2400  -26.8100
            12  C1b C    24.4300  -26.1100
            13  C1b C    25.6200  -26.8100
            14  N1y N    26.8100  -26.1100
            15  C1x C    28.0000  -26.8100
            16  C1x C    29.2600  -26.1100
            17  C1x C    29.2600  -24.7100
            18  C1x C    28.0700  -24.0100
            19  C1x C    26.8100  -24.7100
            20  C8y C    16.1000  -23.8700
            21  S2x S    14.9800  -24.6400
            22  C8y C    15.4000  -25.9700
            23  C8y C    16.7300  -25.9700
            24  C8x C    14.6300  -27.1600
            25  C8y C    15.3300  -28.4200
            26  C8x C    16.7300  -28.4200
            27  C8x C    17.4300  -27.2300
            28  C8y C    16.1000  -22.4700
            29  C8x C    14.9100  -20.3700
            30  C8x C    14.9100  -21.7700
            31  C8x C    17.3600  -21.7700
            32  C8x C    17.3600  -20.3700
            33  C8y C    16.1000  -19.6700
            34  O1a O    16.1000  -18.2700
            35  O1a O    14.6200  -29.6266
BOND        38
            1     2   3 2
            2     3   4 1
            3     4   5 2
            4     5   6 1
            5     6   7 2
            6     2   7 1
            7     2   8 1
            8     8   9 1
            9     8  10 2
            10    5  11 1
            11   11  12 1
            12   12  13 1
            13   13  14 1
            14   14  15 1
            15   15  16 1
            16   16  17 1
            17   17  18 1
            18   18  19 1
            19   14  19 1
            20    9  20 2
            21   20  21 1
            22   21  22 1
            23   22  23 1
            24    9  23 1
            25   22  24 2
            26   24  25 1
            27   25  26 2
            28   26  27 1
            29   23  27 2
            30   20  28 1
            31   29  30 2
            32   30  28 1
            33   31  32 1
            34   32  33 2
            35   29  33 1
            36   33  34 1
            37   28  31 2
            38   25  35 1

» Japanese version   » Back

KEGG   DRUG: Raloxifene
Entry
D08465                      Drug                                   
Name
Raloxifene (INN);
Eviden (TN);
Raxeto (TN)
Formula
C28H27NO4S
Exact mass
473.1661
Mol weight
473.58
Structure
Simcomp
Class
Hormonal agent
 DG01619  Estrogen receptor antagonist/modulator
  DG01621  Selective estrogen receptor modulator
Musculo-skeletal system agent
 DG03232  Osteoporosis agent
Remark
Same as: C07228
ATC code: G03XC01
Chemical structure group: DG00476
Product (DG00476): D02217<JP/US> D10606<JP>
Efficacy
Osteoporosis agent, Selective estrogen receptor modulator (SERM)
Comment
Benzothiophene derivative
Target
NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]
  Pathway
hsa04915  Estrogen signaling pathway
hsa04961  Endocrine and other factor-regulated calcium reabsorption
Structure map
map07043  Antineoplastics - hormones
map07047  Osteoporosis drugs
map07226  Progesterone, androgen and estrogen receptor agonists/antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 G GENITO URINARY SYSTEM AND SEX HORMONES
  G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
   G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
    G03XC Selective estrogen receptor modulators
     G03XC01 Raloxifene
      D08465  Raloxifene (INN)
Drug groups [BR:br08330]
 Hormonal agent
  DG01619  Estrogen receptor antagonist/modulator
   DG01621  Selective estrogen receptor modulator
    DG00476  Raloxifene
     D08465  Raloxifene
 Musculo-skeletal system agent
  DG03232  Osteoporosis agent
   DG00476  Raloxifene
    D08465  Raloxifene
Target-based classification of drugs [BR:br08310]
 Nuclear receptors
  Estrogen like receptors
   Estrogen receptor
    NR3A (ESR)
     D08465  Raloxifene (INN)
Drug groups [BR:br08330]
 Hormonal agent
  DG01619  Estrogen receptor antagonist/modulator
   DG01621  Selective estrogen receptor modulator
    DG00476  Raloxifene
 Musculo-skeletal system agent
  DG03232  Osteoporosis agent
   DG00476  Raloxifene
Other DBs
CAS: 84449-90-1
PubChem: 96025151
ChEBI: 8772
PDB-CCD: RAL[PDBj]
LigandBox: D08465
NIKKAJI: J22.982B
LinkDB
KCF data

ATOM        34
            1   C8y C    18.6200  -17.5000
            2   C8x C    18.6200  -18.9000
            3   C8x C    19.8100  -19.6000
            4   C8y C    21.0700  -18.9000
            5   C8x C    21.0700  -17.5000
            6   C8x C    19.8100  -16.8000
            7   C5a C    17.4300  -16.8000
            8   C8y C    16.2400  -17.5000
            9   O5a O    17.4300  -15.4000
            10  O2a O    22.2600  -19.6000
            11  C1b C    23.4500  -18.9000
            12  C1b C    24.6400  -19.6000
            13  N1y N    25.8300  -18.9000
            14  C1x C    27.0900  -19.6000
            15  C1x C    28.3500  -18.9000
            16  C1x C    28.3500  -17.5000
            17  C1x C    27.1600  -16.8000
            18  C1x C    25.8300  -17.5000
            19  C8y C    15.1200  -16.6600
            20  S2x S    14.0000  -17.4300
            21  C8y C    14.4200  -18.7600
            22  C8y C    15.7500  -18.7600
            23  C8x C    13.6500  -19.9500
            24  C8y C    14.3500  -21.2800
            25  C8x C    15.7500  -21.2800
            26  C8x C    16.4500  -20.0200
            27  C8y C    15.1200  -15.2600
            28  C8x C    13.9300  -13.1600
            29  C8x C    13.9300  -14.5600
            30  C8x C    16.3800  -14.5600
            31  C8x C    16.3800  -13.1600
            32  C8y C    15.1200  -12.4600
            33  O1a O    15.1200  -11.0600
            34  O1a O    13.6500  -22.4700
BOND        38
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     7   9 2
            10    4  10 1
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   17  18 1
            19   13  18 1
            20    8  19 2
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24    8  22 1
            25   21  23 2
            26   23  24 1
            27   24  25 2
            28   25  26 1
            29   22  26 2
            30   19  27 1
            31   28  29 2
            32   29  27 1
            33   30  31 1
            34   31  32 2
            35   28  32 1
            36   32  33 1
            37   27  30 2
            38   24  34 1

» Japanese version   » Back

DBGET integrated database retrieval system